image
CRISPR Therapeutics AG CRSP
Healthcare - Biotechnology - NASDAQ - CH
Watchlist
$ 44.04
0.273 %
$ 3.78 B
Market Cap
-10.15
P/E
INCOME STATEMENT
35 M REVENUE
-90.57%
Growth Rates
1Year -90.57%
3Years -66.28%
5Years -34.47%
7Years -2.23%
10Years 0.00%
-467 M OPERATING INCOME
-109.66%
Growth Rates
1Year -109.66%
3Years -31.02%
5Years -61.49%
7Years -32.62%
10Years -53.02%
-366 M NET INCOME
-138.43%
Growth Rates
1Year -138.43%
3Years -25.35%
5Years -45.31%
7Years -27.10%
10Years -48.98%
EFFICIENCY
Earnings Waterfall CRISPR Therapeutics AG
image
Revenue 35 M
Cost Of Revenue -2.31 M
Gross Profit 37.3 M
Operating Expenses 504 M
Operating Income -467 M
Other Expenses -100 M
Net Income -366 M

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014
REVENUE
Revenue 35.0 371.2 0.4 913.1 0.5 289.6 3.1 41.0 5.2 0.2 0
GROSS PROFIT
Cost Of Revenue (2.3) 130.2 110.2 18.0 269.4 179.4 113.8 69.8 42.2 12.6 1.5
Gross Profit 37.3 241.0 (109.8) 895.1 (268.9) 110.2 (110.6) (28.8) (37.1) (12.3) (1.5)
OPERATING INCOME
Operating Expenses 503.9 462.3 563.3 539.6 355.0 242.8 162.1 105.6 73.3 26.0 6.6
Selling, General and Administrative Expenses 73.0 76.2 102.5 102.8 88.2 63.5 48.3 35.8 31.1 13.4 5.1
Research and Development Expenses 320.7 387.3 461.6 438.6 266.9 179.4 113.8 69.8 42.2 12.6 1.5
Operating Income (466.6) (222.5) (673.2) 373.5 (354.4) 46.7 (158.9) (64.6) (68.1) (25.7) (6.6)
PRE-TAX INCOME
Interest Income Expense 0 0 0 0 0 0 0 0 8.1 0.1 0
Total Other Income 103.9 71.8 22.7 6.0 6.4 20.6 (5.5) (2.0) 45.4 92 K (0.2)
Pre-Tax Income (362.7) (150.7) (650.5) 379.5 (348.1) 67.3 (164.4) (66.6) (22.7) (25.8) (6.9)
NET INCOME
Tax Provision 3.6 2.9 (0.3) 1.9 0.8 0.4 0.6 1.7 0.5 7 K 63 K
Net Income (366.3) (153.6) (650.2) 377.7 (348.9) 66.9 (165.0) (68.4) (23.2) (25.8) (6.8)
EPS 4.34 1.94 8.36 4.97 5.29 1.23 3.44 1.71 1.89 0.88 0.23